Repligen Corp. (RGEN)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

41 SEYON STREET WALTHAM, MA 02453

Repligen Corporation is a global life sciences company that develops and commercializes highly innovative bioprocessing technologies and systems that increase efficiencies in the process of manufacturing biological drugs. Its primary customers are biopharmaceutical drug developers and contract development and manufacturing organizations (CDMOs) worldwide. Its corporate headquarters are located in Waltham, Massachusetts, with additional administrative and manufacturing operations worldwide. The majority of its manufacturing sites are located within the U.S. (California, Massachusetts, New Jersey and New York), and outside of the U.S. it has sites in Estonia, Germany, Ireland, the Netherlands and Sweden.

Data as of 2021-09-19 12:05:57 -0400
Market Cap16.85 Billion Shares Outstanding54.904 Million Avg 30-day Volume345.342 Thousand
P/E Ratio168.61478 Dividend Yield EPS1.79
Price/Sales33.14 Debt to Equity1.26 EBITDA154.621 Million
Price to Book Value10.51 Forward PE113.04 Enterprise Value16.365 Billion
Total Cash734.327 Million Current Debt332.342 Million Gross Profit298.979 Million
BETA1.03426 52-week High/Low310.69 / 138.0 Next Earnings Date2021-11-04 Price to Cash FLow (P/CF) 302.4879
Data provided by IEX Cloud
View SEC Filings from RGEN instead.

View recent insider trading info

Funds Holding RGEN (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RGEN BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

55.8 Thousand total shares from 29 transactions

Exercise Derivative Conversion (M)

28.5 Thousand total shares from 2 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

DAWES KAREN A

  • Director
93,647 2021-09-14 8

HUNT ANTHONY CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
214,649 2021-09-09 8

GEBSKI CHRISTINE SEE REMARKS

  • Officer
33,318 2021-09-01 4

KURIYEL RALF SENIOR VP, R&D

  • Officer
17,354 2021-08-30 7

RYAN THOMAS F JR

  • Director
971 2021-08-04 5

SNODGRES JON CHIEF FINANCIAL OFFICER

  • Officer
31,893 2021-05-14 6

MUIR GLENN P

  • Director
7,513 2021-05-13 1

BARTHELEMY NICOLAS

  • Director
3,058 2021-05-13 2

EGLINTON MANNER CARRIE

  • Director
1,608 2021-05-13 1

MHATRE ROHIN

  • Director
1,608 2021-05-13 1

BYLUND JAMES SVP, GLOBAL OPERATIONS & IT

  • Officer
6,324 2021-04-06 2

COX JOHN

  • Director
923 2020-03-24 0

COOPER GLENN L MD

  • Director
35,709 2019-05-23 0

EDDLEMAN ROY T

  • 10% Owner
No longer subject to file 2018-08-09 0

BENJAMIN HOWARD VP BUSINESS DEVELOPMENT

  • Officer
33,908 2017-12-14 0

RUSCHE JAMES R SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2016-12-31 0

GOLDBERG ALFRED LEWIS

  • Director
40,331 2015-05-21 0

HERLIHY WALTER C PRESIDENT, CEO

  • Officer
  • Director
262,430 2015-05-12 0

GRIFFITH MICHAEL A

  • Director
1,932 2014-11-10 0

WITT DANIEL P SENIOR VICE PRESIDENT

  • Officer
77,999 2014-06-20 0

KELLY WILLIAM J CHIEF ACCOUNTING OFFICER

  • Officer
5,456 2014-02-27 0

HENRY EARL WEBB

  • Director
21,380 2013-05-09 0

LIEBER JONATHAN I CFO

  • Officer
15,000 2013-02-28 0

SPURR ROBERT CHIEF COMMERCIAL. OFFICER

  • Officer
10,000 2012-03-12 0

HALL MICHAEL CHIEF MEDICAL OFFICER

  • Officer
5,000 2012-03-12 0

RICH ALEXANDER

  • Director
0 2011-12-15 0

BVF PARTNERS L P/IL

BIOTECHNOLOGY VALUE FUND L P

BIOTECHNOLOGY VALUE FUND II LP

BVF INVESTMENTS LLC

LAMPERT MARK N

BVF INC/IL

  • 10% Owner
  • INDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNERINDIRECT BENEFICIAL OWNER
No longer subject to file 2009-07-06 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

DAWES KAREN A - Director

2021-09-15 17:46:39 -0400 2021-09-14 S 108 $295.02 d 93,674 direct 2.3409 2.3409 2 0.0 1

DAWES KAREN A - Director

2021-09-15 17:46:39 -0400 2021-09-14 S 13 $290.02 d 93,908 direct 2.3409 2.3409 2 0.0 1

DAWES KAREN A - Director

2021-09-15 17:46:39 -0400 2021-09-14 S 101 $294.06 d 93,782 direct 2.3409 2.3409 2 0.0 1

DAWES KAREN A - Director

2021-09-15 17:46:39 -0400 2021-09-14 S 27 $295.82 d 93,647 direct 2.3409 2.3409 2 0.0 1

DAWES KAREN A - Director

2021-09-15 17:46:39 -0400 2021-09-14 S 25 $292.34 d 93,883 direct 2.3409 2.3409 2 0.0 1

HUNT ANTHONY - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-13 18:24:22 -0400 2021-09-09 S 1,631 $296.09 d 189,503 direct 0.6452 0.6452 2 0.0 1

HUNT ANTHONY - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-13 18:24:22 -0400 2021-09-09 M 25,000 $32.40 a 214,495 direct 0.6452 0.6452 2 0.0 1

HUNT ANTHONY - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-13 18:24:22 -0400 2021-09-09 M 25,000 a 25,154 direct

HUNT ANTHONY - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-13 18:24:22 -0400 2021-09-09 S 14,825 $294.90 d 191,134 direct 0.6452 0.6452 2 0.0 1

HUNT ANTHONY - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-13 18:24:22 -0400 2021-09-09 S 8 $296.58 d 189,495 direct 0.6452 0.6452 2 0.0 1

HUNT ANTHONY - Director - Officer CHIEF EXECUTIVE OFFICER

2021-09-13 18:24:22 -0400 2021-09-09 S 8,536 $294.22 d 205,959 direct 0.6452 0.6452 2 0.0 1

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 S 851 $285.44 d 93,921 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 S 405 $282.53 d 96,540 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 M 3,459 $38.76 d 97,380 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

GEBSKI CHRISTINE - Officer SEE REMARKS

2021-09-02 16:33:36 -0400 2021-09-01 S 3,377 $285.33 d 33,318 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 S 1,107 $284.64 d 94,772 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 S 196 $281.68 d 96,945 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 M 3,459 a 0 direct

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 S 661 $283.56 d 95,879 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

DAWES KAREN A - Director

2021-09-02 16:29:25 -0400 2021-09-01 S 239 $280.27 d 97,141 direct 1.2585 -0.9746 1.2585 2 -0.9746 6

KURIYEL RALF - Officer SENIOR VP, R&D

2021-09-02 06:54:15 -0400 2021-08-30 S 4,001 $282.13 d 17,354 direct 1.3447 2.2493 2.6201 3 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-18 S 78 $260.91 d 93,961 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-18 S 302 $257.66 d 95,061 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-18 S 388 $259.93 d 94,039 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-18 S 40 $262.31 a 93,921 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-18 S 634 $258.91 d 94,427 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-17 S 8,580 $254.09 d 97,788 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-17 S 924 $251.15 d 111,953 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-17 S 194 $256.43 d 95,363 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-17 S 4,665 $253.34 d 106,368 direct 1.2905 5.0021 5.0021 6 0.0 1

HUNT ANTHONY - Director - Officer CHIEF EXECUTIVE OFFICER

2021-08-18 16:16:30 -0400 2021-08-17 G 1,000 d 189,495 direct 1.2059 5.0586 5.5671 5 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-17 S 2,231 $255.07 d 95,557 direct 1.2905 5.0021 5.0021 6 0.0 1

DAWES KAREN A - Director

2021-08-19 16:42:11 -0400 2021-08-17 S 920 $251.92 d 111,033 direct 1.2905 5.0021 5.0021 6 0.0 1

RYAN THOMAS F JR - Director

2021-08-05 19:33:27 -0400 2021-08-04 S 780 $250.50 d 971 direct 1.907 2.9164 22.1025 22.4417 30 -0.403 4

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
REPLIGEN CORP RGEN 2021-09-21 21:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 20:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 20:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 19:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 19:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 18:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 18:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 17:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 17:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 16:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 16:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 15:45:04 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 15:15:04 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 14:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 14:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 13:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 13:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-21 12:45:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-20 22:15:03 UTC -0.18 0.25 1700000
REPLIGEN CORP RGEN 2021-09-20 21:45:03 UTC -0.18 0.25 1700000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund RGEN -20.0 shares, $-2950.8 2020-09-30 N-PORT
Jackson Variable Series Trust- JNL/Nicholas Convertible Arbitrage Fund RGEN -12255.0 shares, $-1183097.7 2020-03-31 N-PORT
RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund RGEN -1191.0 shares, $-238200.0 2021-01-31 N-PORT
RUSSELL INVESTMENT CO- Sustainable Equity Fund RGEN -2116.0 shares, $-447978.36 2021-04-30 N-PORT
RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund RGEN -5924.0 shares, $-1254170.04 2021-04-30 N-PORT
SCHWAB CAPITAL TRUST- Schwab Hedged Equity Fund RGEN -843.0 shares, $-178471.53 2021-04-30 N-PORT
Nuveen Investment Trust- Nuveen Equity Market Neutral Fund RGEN -1000.0 shares, $-182610.0 2021-05-31 N-PORT
Nuveen Investment Trust II- Nuveen Equity Long/Short Fund RGEN -2100.0 shares, $-383481.0 2021-05-31 N-PORT
RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund RGEN -958.0 shares, $-191235.96 2021-06-30 N-PORT
Advanced Series Trust- AST QMA U.S. Equity Alpha Portfolio RGEN -1300.0 shares, $-259506.0 2021-06-30 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Anti-Beta Fund RGEN -2340.0 shares, $-467110.8 2021-06-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund RGEN -5.0 shares, $-998.1 2021-06-30 N-PORT
Federated Hermes Equity Funds- Federated Hermes Prudent Bear Fund RGEN -1000.0 shares, $-199620.0 2021-06-30 N-PORT
AQR Funds- AQR Alternative Risk Premia Fund RGEN -755.0 shares, $-150713.1 2021-06-30 N-PORT

Elevate your investments